Hi everyone, and welcome to the November edition of the Seaside Ventures newsletter! This month, we’re excited to share a new investment, some great updates from our portfolio companies, and a new Wellness Wednesdays feature. As we get closer to the end of the year, we’re taking a moment to highlight the incredible work of our founders and teams.
—Ryan Roddy, Harrison Valner, & The Seaside Team
We’re excited to share that we’ve joined Paterna Biosciences’ $6M Seed Round, led by SpringTide Ventures. Paterna is tackling male infertility through in vitro spermatogenesis (IVS), which uses stem cells to create viable sperm. This approach could make a huge difference for couples facing male infertility.
With founders like Dr. Alex Pastuzak, Brad Cairns, Ph.D., and Dr. Jim Hotaling, Paterna is addressing the genetic factors behind infertility with science-backed, innovative solutions. Learn more about their work here.
Sensory Cloud, Inc. is teaming up with Hyfe, Inc. to push forward respiratory health and AI-driven diagnostics. It’s an exciting partnership with a lot of potential to improve care.
Read more here.
Somnee’s Smart Sleep Headband is getting some well-deserved attention for improving sleep quality:
Samphire is turning heads in the neurotech space for its device aimed at managing menstruation and PMS:
ZBiotics was recently featured in Entrepreneur, where they shared their journey from launching a hangover cure to building a multimillion-dollar business.
Catch their story here.
Plan A was spotlighted in Fortune, discussing the push for male birth control and the hurdles that come with it in today’s political climate.
Read the article here.
This month, Ryan Roddy digs into how neurotechnology is opening new doors for improving brain health, treating mental health issues, and enhancing cognitive performance.
Read the full article here.
Thanks for taking the time to catch up with us this month. As always, we’re grateful for your continued support and look forward to sharing more updates soon.
All the best,